| 3.72 Data as of May 21 |  0.00 / 0.00%Today’s Change | 3.52 Today|||52-Week Range 11.16 | -6.77% Year-to-Date |
| Previous close | 3.72 |
| Today’s open | 3.72 |
| Day’s range | 3.72 - 3.80 |
| Volume | 14,835 |
| Average volume (3 months) | 33,840 |
| Market cap | $105.7M |
| Dividend yield | -- |
| Earnings growth (last year) | -650.00% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -57.61% |
| P/E ratio | NM |
| Price/Sales | 5.36 |
| Price/Book | 0.45 |
| Today’s change | Today’s % change | |
|---|---|---|
| ATHXAthersys Inc | -0.07 | -3.63% |
| APRIApricus Biosciences ... | +0.06 | +1.79% |
| NNVCNanoViricides Inc | -0.01 | -1.61% |
| ACURAcura Pharmaceutical... | -0.10 | -4.17% |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $14.8M |
| Annual profit (last year) | -$4.5M |
| Net profit margin | -50.63% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Russell H. Plumb, MBA, CPA |
Chief Financial Officer & Head-Investor Relations Damian T. Lismore |
Corporate headquarters Rockville, Maryland |
.
